Avecho Archives | Page 2 of 3 | Cannabiz

Avecho turns to new investors to raise funds for CBD clinical trial

by Steve Jones May 9, 2023April 30, 2024

Over-the-counter CBD hopeful Avecho Biotechnology will turn its focus on generating capital from new investors after […]

Financial results: Avecho; Elixinol; Epsilon; Creso Pharma

by Steve Jones May 2, 2023April 30, 2024

Financial results: Elixinol; Emyria; Epsilon; Avecho; Creso Pharma; AusCann; MGC Pharma; Botanix; Zelira

by Martin Lane and Steve Jones March 1, 2023April 30, 2024

Lambert researchers to study Avecho CBD soft gel for novel indications

by Steve Jones February 22, 2023April 30, 2024

Company news: Avecho; Levin Health; Cannatrek; Releaf Group; Bod Science

by Martin Lane and Steve Jones December 22, 2022April 29, 2024

Avecho chief warns of placebo dangers as firms roll out CBD clinical trials

by Steve Jones October 20, 2022April 29, 2024

Avecho study shows TPM formulation has ‘superior absorption to Epidyolex’

by Steve Jones September 19, 2022April 29, 2024

Financial results: Avecho; AusCann; Zelira; Elixinol; Cann Group; Incannex; Creso Pharma; Medlab; Rua Bioscience

by Steve Jones and Martin Lane September 1, 2022April 29, 2024

S3 registration will be a game of skill, not speed

by Martin Lane August 25, 2021April 26, 2024

Avecho targets insomnia in drive for S3 registration

by Martin Lane May 28, 2021April 26, 2024